| Natalia O Litbarg, MD | |
|
2160 S First Ave, 101-1740 Loyola University Medical Center, Maywood, IL 60153 | |
| (708) 216-9000 | |
| (708) 216-9033 |
| Full Name | Natalia O Litbarg |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Nephrology |
| Location | 2160 S First Ave, Maywood, Illinois |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821075177 | NPI | - | NPPES |
| 36106979 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 36106979 (Illinois) | Primary |
| Entity Name | The Board Of Trustees Of The University Of Illinois |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386863819 PECOS PAC ID: 3072422716 Enrollment ID: O20031112000158 |
News Archive
In 2015, then President Barack Obama launched a precision medicine initiative, saying that its promise was "delivering the right treatments, at the right time, every time to the right person.
Results from two major multi-center clinical trials presented at the Digestive Disease Week in New Orleans independently confirmed that the effects of endoscopic radiofrequency ablation (RFA) for eradicating a pre-cancerous condition of the esophagus called Barrett's esophagus are durable in the long-term. In a plenary scientific presentation titled "Endoscopic Radiofrequency Ablation for Barrett's Esophagus: Five-year Durability Outcomes from a Prospective Multi-Center Trial," patients with Barrett's esophagus were treated with endoscopic RFA using the HALO system.
International Stem Cell Corporation, www.internationalstemcell.com, and Insight Bioventures India Private Limited, announced today that they have signed a letter of intent concerning funding and establishment of an Indian affiliate of ISCO. The goal is to establish world-class development and manufacturing operations for ISCO's research and pharmaceutical products in India, including its Lifeline Cell Technology research products and human corneal tissue, CytoCor, for treatment of corneal vision impairment and testing of chemicals.
Scripps Research Institute scientists have shown for the first time that the neurotransmitter serotonin uses a specialized signaling pathway to mediate biological functions that are distinct from the signaling pathways used by hallucinogenic substances. The new findings could have a profound effect on the development of new therapies for a number of disorders, including schizophrenia and depression.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Natalia O Litbarg, MD 2160 S First Ave, 101-1740 Loyola University Medical Center, Maywood, IL 60153 Ph: (708) 216-9000 | Natalia O Litbarg, MD 2160 S First Ave, 101-1740 Loyola University Medical Center, Maywood, IL 60153 Ph: (708) 216-9000 |
News Archive
In 2015, then President Barack Obama launched a precision medicine initiative, saying that its promise was "delivering the right treatments, at the right time, every time to the right person.
Results from two major multi-center clinical trials presented at the Digestive Disease Week in New Orleans independently confirmed that the effects of endoscopic radiofrequency ablation (RFA) for eradicating a pre-cancerous condition of the esophagus called Barrett's esophagus are durable in the long-term. In a plenary scientific presentation titled "Endoscopic Radiofrequency Ablation for Barrett's Esophagus: Five-year Durability Outcomes from a Prospective Multi-Center Trial," patients with Barrett's esophagus were treated with endoscopic RFA using the HALO system.
International Stem Cell Corporation, www.internationalstemcell.com, and Insight Bioventures India Private Limited, announced today that they have signed a letter of intent concerning funding and establishment of an Indian affiliate of ISCO. The goal is to establish world-class development and manufacturing operations for ISCO's research and pharmaceutical products in India, including its Lifeline Cell Technology research products and human corneal tissue, CytoCor, for treatment of corneal vision impairment and testing of chemicals.
Scripps Research Institute scientists have shown for the first time that the neurotransmitter serotonin uses a specialized signaling pathway to mediate biological functions that are distinct from the signaling pathways used by hallucinogenic substances. The new findings could have a profound effect on the development of new therapies for a number of disorders, including schizophrenia and depression.
› Verified 8 days ago
Dr. Cathryn T Sawalski, DO, MBA Nephrology Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Suhana Elamsenthil, MD Nephrology Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Holly Kramer, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2160 S First Ave, 101-1740 Loyola University Medical Center, Maywood, IL 60153 Phone: 708-216-9000 Fax: 708-216-9033 | |
Dr. Stephanie Bochen Tsai, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-9000 | |
Nicholas Poellinger, MD Nephrology Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 888-584-7888 | |
Sofia Ahmed, MD Nephrology Medicare: Medicare Enrolled Practice Location: 2160 S 1st Ave, Maywood, IL 60153 Phone: 708-216-8757 | |
Shelly Lo, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2160 S 1st Ave, Luh - North Ent., Rm. 7604, Maywood, IL 60153 Phone: 708-216-3304 Fax: 708-216-1259 |